Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Comprehensive multiplatform biomarker analysis of 350 hepatocellular carcinomas identifies potential novel therapeutic options.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Comprehensive multiplatform biomarker analysis of 350 hepatocellular carcinomas identifies potential novel therapeutic options.
Comprehensive multiplatform biomarker analysis of 350 hepatocellular carcinomas identifies potential novel therapeutic options. J Surg Oncol. 2016 Jan; 113(1):55-61.
View in:
PubMed
subject areas
Adult
Adult
Aged
Aged
Aged, 80 and over
Aged, 80 and over
Antineoplastic Agents
Antineoplastic Agents
beta Catenin
beta Catenin
Biomarkers, Tumor
Biomarkers, Tumor
Carcinoma, Hepatocellular
Carcinoma, Hepatocellular
Erlotinib Hydrochloride
Erlotinib Hydrochloride
Female
Female
Gene Expression Profiling
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Gene Expression Regulation, Neoplastic
Humans
Humans
Immunohistochemistry
Immunohistochemistry
Liver Neoplasms
Liver Neoplasms
Lung Neoplasms
Lung Neoplasms
Male
Male
Middle Aged
Middle Aged
Molecular Targeted Therapy
Molecular Targeted Therapy
Mutation
Mutation
Niacinamide
Niacinamide
Phenylurea Compounds
Phenylurea Compounds
Poly(ADP-ribose) Polymerase Inhibitors
Poly(ADP-ribose) Polymerase Inhibitors
Protein-Tyrosine Kinases
Protein-Tyrosine Kinases
Retrospective Studies
Retrospective Studies
Tumor Suppressor Protein p53
Tumor Suppressor Protein p53